NLRC5/MHC class I transactivator is a target for immune evasion in cancer
Yoshihama, Sayuri, Roszik, Jason, Downs, Isaac, Meissner, Torsten B., Vijayan, Saptha, Chapuy, Bjoern, Sidiq, Tabasum, Shipp, Margaret A., Lizee, Gregory A., Kobayashi, Koichi S.
Published in Proceedings of the National Academy of Sciences - PNAS (24.05.2016)
Published in Proceedings of the National Academy of Sciences - PNAS (24.05.2016)
Get full text
Journal Article
The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy
Chaudhri, Apoorvi, Bu, Xia, Wang, Yunfei, Gomez, Michael, Torchia, James A, Hua, Ping, Hung, Shao-Hsi, Davies, Michael A, Lizee, Gregory A, von Andrian, Ulrich, Hwu, Patrick, Freeman, Gordon J
Published in Frontiers in immunology (13.09.2023)
Published in Frontiers in immunology (13.09.2023)
Get full text
Journal Article
Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy
Lyons, Yasmin A, Pradeep, Sunila, Wu, Sherry Y, Haemmerle, Monika, Hansen, Jean M, Wagner, Michael J, Villar-Prados, Alejandro, Nagaraja, Archana S, Dood, Robert L, Previs, Rebecca A, Hu, Wei, Zhao, Yang, Mak, Duncan H, Xiao, Zhilan, Melendez, Brenda D, Lizee, Gregory A, Mercado-Uribe, Imelda, Baggerly, Keith A, Hwu, Patrick, Liu, Jinsong, Overwijk, Willem W, Coleman, Robert L, Sood, Anil K
Published in Oncotarget (14.11.2017)
Published in Oncotarget (14.11.2017)
Get full text
Journal Article
Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention
Bolivar, Ana M., Duzagac, Fahriye, Deng, Nan, Reyes-Uribe, Laura, Chang, Kyle, Wu, Wenhui, Bowen, Charles M., Taggart, Melissa W., Thirumurthi, Selvi, Lynch, Patrick M., You, Y. Nancy, Rodriguez-Pascual, Jesus, Lipkin, Steven M., Kopetz, Scott, Scheet, Paul, Lizee, Gregory A., Reuben, Alexandre, Sinha, Krishna M., Vilar, Eduardo
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2024)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2024)
Get full text
Journal Article
Novel murine glioblastoma models that reflect the immunotherapy resistance profile of a human disease
Chen, Chao-Hsien, Chin, Renee L, Hartley, Genevieve P, Lea, Spencer T, Engel, Brian J, Hsieh, Cheng-En, Prasad, Rishika, Roszik, Jason, Shingu, Takashi, Lizee, Gregory A, Heimberger, Amy B, Millward, Steven W, Hu, Jian, Hong, David S, Curran, Michael A
Published in Neuro-oncology (Charlottesville, Va.) (03.08.2023)
Published in Neuro-oncology (Charlottesville, Va.) (03.08.2023)
Get full text
Journal Article
808 The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances responses to anti-PD-1 immunotherapy
Chaudhri, Apoorvi, Bu, Xia, Wang, Yunfei, Hua, Ping, Hung, Shao-Hsi, Davies, Michael A, Lizee, Gregory A, Andrian, Ulrich von, Hwu, Patrick, Freeman, Gordon
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models
Zhu, Kuichun, Qin, Hong, Cha, Soung-Chul, Neelapu, Sattva S, Overwijk, Willem, Lizee, Gregory A, Abbruzzese, James L, Hwu, Patrick, Radvanyi, Laszlo, Kwak, Larry W, Chang, David Z
Published in Vaccine (14.11.2007)
Published in Vaccine (14.11.2007)
Get full text
Journal Article
Abstract 1705: Identification and validation of neoantigens for developing a preventive vaccine for mismatch-repair deficient cancers
Bowen, Charles, Bolivar, Ana, Chang, Kyle, Wu, Wendy, Reyes-Uribe, Laura, Lizee, Gregory A., Sinha, Krishna, Vilar, Eduardo
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
Hailemichael, Yared, Johnson, Daniel H., Abdel-Wahab, Noha, Foo, Wai Chin, Bentebibel, Salah-Eddine, Daher, May, Haymaker, Cara, Wani, Khalida, Saberian, Chantal, Ogata, Dai, Kim, Sang T., Nurieva, Roza, Lazar, Alexander J., Abu-Sbeih, Hamzah, Fa'ak, Faisal, Mathew, Antony, Wang, Yinghong, Falohun, Adewunmi, Trinh, Van, Zobniw, Chrystia, Spillson, Christine, Burks, Jared K., Awiwi, Muhammad, Elsayes, Khaled, Soto, Luisa Solis, Melendez, Brenda D., Davies, Michael A., Wargo, Jennifer, Curry, Jonathan, Yee, Cassian, Lizee, Gregory, Singh, Shalini, Sharma, Padmanee, Allison, James P., Hwu, Patrick, Ekmekcioglu, Suhendan, Diab, Adi
Published in Cancer cell (09.05.2022)
Published in Cancer cell (09.05.2022)
Get full text
Journal Article
T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12V MUTATION ON HLA-A03:01 IN LUNG CANCER
LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin
Year of Publication 15.08.2024
Get full text
Year of Publication 15.08.2024
Patent
T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12C MUTATION ON HLA-A03:01 IN LUNG CANCER
LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin
Year of Publication 15.08.2024
Get full text
Year of Publication 15.08.2024
Patent
T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12V MUTATION ON HLA-A11:01 IN LUNG CANCER
LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin
Year of Publication 15.08.2024
Get full text
Year of Publication 15.08.2024
Patent
T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12C MUTATION ON HLA-A11:01 IN LUNG CANCER
LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin
Year of Publication 15.08.2024
Get full text
Year of Publication 15.08.2024
Patent
T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12C MUTATION ON HLA-A03:01 IN LUNG CANCER
LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin
Year of Publication 11.07.2024
Get full text
Year of Publication 11.07.2024
Patent
T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12V MUTATION ON HLA-A11:01 IN LUNG CANCER
LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin
Year of Publication 11.07.2024
Get full text
Year of Publication 11.07.2024
Patent
T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12V MUTATION ON HLA-A03:01 IN LUNG CANCER
LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin
Year of Publication 11.07.2024
Get full text
Year of Publication 11.07.2024
Patent
T CELL RECEPTORS TARGETING THE HIGHLY PREVALENT KRAS G12C MUTATION ON HLA-A11:01 IN LUNG CANCER
LIZEE, Gregory A, REUBEN, Alexandre, HEYMACH, John Victor, ZHANG, Minying, JIANG, Peixin
Year of Publication 11.07.2024
Get full text
Year of Publication 11.07.2024
Patent